Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Episenta 300 mg Prolonged-release capsules {equilateral_black_triangle}

Active Ingredient:
sodium valproate
Company:  
Desitin Pharma Ltd See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 17 Jan 2025

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Desitin Pharma Ltd
Company image
Address
Fairbourne Drive, Atterbury, Milton Keynes, Bucks, MK10 9RG, UK
Telephone
+44 (0) 1908 488817
Medical Information Direct Line
+44 (0) 1908 488817
E-mail
[email protected]
WWW
www.desitin.co.uk